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Background: Type 2 diabetes mellitus patients with an acute coronary event (ACE) experience decreased quality of
life and increased distress. According to the American Diabetes Association, discharge from the hospital is a time of
increased distress for all patients. Tailored support specific to diabetes is scarce in that period. We developed an
intervention based on Bandura’s Social Cognitive Theory, Leventhal’s Common Sense Model, and results of focus
groups. The aim of this study is to evaluate the effectiveness of the intervention to reduce distress in type 2
diabetes patients who experienced a first ACE.
Methods: Randomised controlled trial. Two hundred patients are recruited in thirteen hospitals. A diabetes nurse
visits the patients in the intervention group (n = 100) at home within three weeks after discharge from hospital, and
again after two weeks and two months. The control group (n = 100) receives a consultation by telephone. The
primary outcome is diabetes-related distress, measured with the Problem Areas in Diabetes (PAID) questionnaire.
Secondary outcomes are well-being, health status, anxiety, depression, HbA1c, blood pressure and lipids. Mediating
variables are self-management, self-efficacy and illness representations. Outcomes are measured with questionnaires
directly after discharge from hospital and five months later. Biomedical variables are obtained from the records from
the primary care physician and the hospital. Differences between groups in change over time are analysed according
to the intention-to-treat principle. The Holm-Bonferroni correction is used to adjust for multiplicity.
Discussion: Type 2 diabetes patients who experience a first ACE need tailored support after discharge from the
hospital. This trial will provide evidence on the effectiveness of a supportive intervention in reducing distress in these
patients.
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General background
Type 2 diabetes patients have an increased risk of an
acute cardiac event (ACE) [1-3]. Self-management by pa-
tients and their families plays a crucial role to prevent
complications in type 2 diabetes. Despite the patients’
own efforts on self-management, they may be con-
fronted with an ACE; 19-23% of the ACE patients have a
history of diabetes [4-6]. This confrontation may evoke
depressive feelings, not only because of the physical
problems, but also because they may experience a loss of
control and decreased self-efficacy. In addition, self-
management may be complicated, since patients also
have to cope with the ACE in daily life [7,8]. It is known
that type 2 diabetes and cardiac disease are both associ-
ated with decreased quality of life (QOL) [9-11]. The
combination of the two conditions decreases QOL even
more [12-14]. Taken all these factors into account, it
seems that self-management support is of high import-
ance in the first period after the occurrence of an ACE
[15]. This should address both the individual patient and
the partner, since both have to adapt to the new situ-
ation. Furthermore, partners influence the way type 2
diabetes patients cope with their condition [16,17].
Cardiac rehabilitation is widely recommended for pa-
tients with an ACE. However, the benefit of the rehabili-
tation program on physical functioning is significantly
lower in type 2 diabetes patients than in patients without
diabetes [18]. Appointment adherence is lower and attri-
tion is greater in type 2 diabetes patients as well [19].
Altogether, the above mentioned factors may result in
increased diabetes-related distress in type 2 diabetes pa-
tients after a first ACE. Distress is an important con-
struct covering concerns about disease management,
support, emotional burden, and access to care. Loss of
control, feelings of failure and lowered self-efficacy may
also play a role [20,21]. Distress in type 2 diabetes is as-
sociated with several clinically relevant aspects such as
medication adherence and glycaemic control [22,23].
Discharge from the hospital might be a period of in-
creased distress. The American Diabetes Association
recommends discharge planning that should include
1) medication reconciliation; 2) structured discharge
communication; 3) discharge summary transmitted to pri-
mary care physician; 4) follow-up visits scheduled with
both primary and secondary care providers. Medication
adherence and health status, combined with optimal sec-
ondary prevention therapy are also important topics to
discuss.
Self-management support that address the specific
physical and psychological problems of type 2 diabetes
patients who had a recent ACE during the period imme-
diately after discharge from hospital is lacking. There-
fore, we developed a theory-based tailored interventionfor these patients. This paper describes the intervention
and the protocol of the randomised controlled trial
(RCT) to evaluate the effectiveness on reducing distress.
We hypothesise that an intervention that succeeds in
increasing self-efficacy and improving illness representa-
tions will lead to better self-management and decrease
diabetes-related distress (Figure 1).
Theoretical framework of the intervention
Central in our intervention are two psychological con-
cepts that have proven to be key factors of self-
management of chronic illness: self-efficacy and illness
representations.
Self-efficacy
Self-efficacy can be defined as a person’s confidence in
his or her ability to perform specific behaviours that are
considered to result in beneficial outcomes. According
to Bandura’s Social Cognitive Theory, self-efficacy is po-
tentially modifiable and can have an impact on health
status, motivation levels and adherence to prescribed
regimens [24]. Interventions focusing on improving self-
efficacy are successful in improving chronic disease out-
comes as well [25,26], such as better self-management in
diabetes [27] and cardiac patients [28]. Better self-
management can decrease diabetes-related distress with-
out affecting HbA1c [29,30]. A strong relationship exists
between self-efficacy and disease-related distress on the
one hand and self-management behaviour on the other
[31]. Several strategies can be utilised to promote self-
efficacy [24,32] such as identifying and reinforcing the
patient’s past and present successes or accomplishments
of self-management activities.
Illness representations
According to Leventhal’s Common Sense Model of self-
regulation (CSM), individuals make sense of a health
threat by developing their own cognitive and emotional
representations of that threat [33]. These representations
have an impact on people’s coping behaviour. Cognitive
representations include identity (beliefs about the condi-
tion’s label and associated symptoms), timeline (beliefs
about the expected duration of the condition), conse-
quences (beliefs about the impact of the condition on
physical, social and psychological well-being), curability/
controllability (beliefs about whether the condition can
be cured or kept under control through medical treat-
ment and/or self-management behaviour) and cause
(beliefs about causes of the condition). The coherence
domain concerns beliefs about how well one under-
stands the condition. Emotional representations refer to
the emotions generated by the condition. Positive illness
representations are associated with increased quality of
life, better self-management and decreased distress
Self-efficacy 
Illness representations 
Self-management Diabetes related distress 
Figure 1 Hypothesis.
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representations in type 2 diabetes have shown positive
effects on well-being and self-management [36].
Self-efficacy and illness representations are related:
more self-efficacious persons are more likely to perceive
their illnesses to be controllable [37]. This may improve
medication adherence [38].
Focus groups as a basis for the intervention
The intervention is also based on the results of focus
groups. Using qualitative methods, we explored the needs
and wishes of type 2 diabetes patients and their partners
regarding support after an ACE. Participants (n = 17, 71%
male, aged 61–77) attended the focus groups within six
months after discharge from the hospital after their first
ACE. The focus groups demonstrated that the patients
perceive themselves as a specific group of ACE patients:
they have to cope with several diseases at the same time
and experience more difficulties after discharge than ACE
patients without type 2 diabetes. The participants reported
a lack of information supply and missed support from the
health care professionals. They had difficulties in coping
with physical exercise, sexuality, medication use and the
monitoring scheme of the different healthcare profes-
sionals. Most patients had no difficulties with nutrition.
Participants pointed out that their partners were worried,
resulting in overprotective behaviour. Both type 2 diabetes
patients and their partners welcomed an individualised
self-management support program provided shortly after
discharge from hospital. Attention should be paid to the
topics described above. Furthermore, the intervention
should be tailored to the individual patient’s home envir-
onment and involve close relatives.
Methods
The Medical Research Ethics Committee of the University
Medical Center Utrecht has approved the study protocol
(Protocol number: 10-403).
Study design and selection criteria
The study is designed as a randomised controlled trial.
Inclusion criteria:
 History of type 2 diabetes (>1 year)
 Discharged from the hospital after a first acute
coronary event defined as a Myocardial Infarction
(MI), Coronary Artery Bypass Graft (CABG)procedure or Percutaneous Transluminal Coronary
Angioplasty (PTCA)
 Sufficient knowledge of the Dutch language
Exclusion criteria:
 A serious illness or condition preventing full
participation
 Inability to fill in questionnaires
Recruitment
Participants are recruited via their cardiologists in thirteen
hospitals, in three different regions across the Netherlands.
Within two weeks after discharge from hospital the pa-
tients are invited to participate. Patients who agree to par-
ticipate are asked to provide written informed consent.
We use a modified informed consent procedure (Section),
to ensure that patients are unaware of the two different
conditions [39].
Modified informed consent procedure
Patients meeting the inclusion criteria will receive the
following information in a general information letter:
1) A program has been developed to support patient
with type 2 diabetes in the period after discharge
from the hospital.
2) We cannot inform you about the exact contents of
this program.
3) To evaluate whether the program is effective, we ask
you to complete a set of questionnaires twice
(directly after discharge and five months later).
4) After your consent you will be informed about your
program. You can decide whether you still want to
participate.
5) There are no risks associated with participation in
this study.
After randomisation participants will be further in-
formed about the program.
Randomisation
After informed consent, patients are randomised to the
intervention or the control group. Randomisation is gen-
erated at the patient level by a computerised random-
number generator at the research centre.
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A trained diabetes nurse (see below), visits the patients
in the intervention group at home three times. The first
visit (65 minutes) is within three weeks after discharge
from the hospital; the second visit (45 minutes) is two
weeks later and the third visit (45 minutes) is two
months after the second home visit. The number of
visits was established based on the results of previous re-
search [40-42] and on feasibility of implementation on a
larger scale if the intervention proves effective. During the
sessions, the nurse follows a protocol and the patient uses
a handbook with assignments and homework. We encour-
age the patients to invite a partner or close friend who is
actively involved in the discussions during the visits.
As a result of the focus group discussions, ten topics
were chosen to be discussed during the visits: physical
activity, sexuality, pharmacotherapy, the monitoring
scheme with different health care professionals, coping
together with the partner, coping with both diabetes and
the ACE in daily life, (depressive) feelings, nutrition/diet,
other.
We incorporate strategies of motivational interviewing
in our intervention. Motivational interviewing is a
patient-centred counselling approach that actively en-
gages patients in defining experienced problem areas
and potential strategies to tackle issues related to illness
[43,44]. Interventions based on motivational interview-
ing show positive effects on patients’ self-management,
self-efficacy and quality of life [45].
In the first visit, the focus is on information exchange
and strengthening self-efficacy. To explore the individual
needs of the patient, the patient is asked to indicate to
what extent problems are experienced on the list of ten
topics, and which three are the most important. The
nurse discusses these three topics in depth, using tech-
niques of motivational interviewing. Next the participant
sets goals he/she wants to achieve in the next two weeks.
The nurse coaches the patient and helps formulate plans
to reach these goals. At the end of the session the pa-
tient receives a set of leaflets with more information on
ACE and diabetes and the homework for the upcoming
two weeks is discussed. The patient is asked to keep
daily a log to track strategies for coping with events re-
lating to the topics discussed, and to fill out questions
assessing representations of diabetes and the ACE. These
questionnaires function as a structuring tool during the
second visit, not as an outcome measure.
The focus of the second visit is on strengthening self-
efficacy and changing misrepresentations and negative
representations of illness. To strengthen self-efficacy, the
log is discussed to explore the strategies the participant
used to cope with problems. The illness representations
questionnaires are discussed, to change misrepresentations
and negative representations of diabetes and ACE in orderto create more congruent illness representations. The goals
formulated during the first visit are evaluated. New goals
for the coming two months are formulated, including strat-
egies to reach them. Furthermore, the patient is asked to
use now weekly a log to track strategies for coping with dif-
ficulties in daily life.
The focus of the third visit is on the future. The log is
discussed to enhance self-efficacy. The patient indicates
again to what extent problems are experienced on the
list of topics from the first visit. The remaining problems
are discussed in more detail and the patient is coached
to propose strategies to deal with them. The goals for-
mulated during the second visit are evaluated and new
goals are formulated, along with strategies to reach
them. At the end of the visit uncertainties for the future
are discussed.
Nine diabetes nurses experienced with motivational
interviewing followed a six hours training for the specific
purpose of this study. A GP gave general information
about ACE. Patients experiences in the hospital were
discussed by a hospital based cardiac nurse and the ex-
periences after discharge were discussed by a type 2 dia-
betes patient who recently had an ACE. A psychologist
taught techniques to strengthen self-efficacy and to
intervene on illness representations. The executing re-
searcher discussed the different aspects of the study. To
check whether the nurses performed the visits correctly
and used the information from the training, we will
evaluate the audio recordings of all visits of one of the
patients of each nurse. In addition, meetings will be
organised twice a year with the nurses and executing re-
searcher to evaluate the nurses’ performance.
The drafted intervention became definite after a pilot
study in three patients with three different nurses. Over-
all, the nurses and patients were positive about the con-
tent of the intervention. The intended duration of the
visits seemed to be too short and we prolonged the three
visits with five minutes each.
Attention control group
In this study, an attention control group is used. The ra-
tionale for using an attention control group (instead of a
‘usual care’ control group) is to distinguish the effective-
ness of an intervention tailored to the specific needs of the
patient from personal attention without tailored support.
In other words: people in both groups receive personal at-
tention, but the intervention group receives tailored sup-
port whereas the control group does not. The intervention
group receives much more attention than the control
group. However designing of an attention control group
with a comparable amount of attention is unfeasible. The
control group in this study gets significantly more atten-
tion with regard to their ACE in relation to their diabetes
compared to usual care.
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(approximately 15 minutes) by telephone, within three
weeks after discharge from hospital. The aim of the con-
sultation is to give them the opportunity to discuss how
they feel and function in the period after discharge; how-
ever, no support is provided. Two members of the re-
search team conduct the consultations following a semi-
structured protocol. They are instructed to follow the
protocol and to give the patient personal attention, with-
out giving any advice or support regarding treatment
and self-management. The focus of the consultation is
on the topics which are of high importance to the pa-
tient. Open questions are used to stimulate the discus-
sion (e.g. “Can you tell me how you have been doing
since you got home”).
Measures
All participating patients receive a set of questionnaires
(described in Table 1) at their homes, directly after dis-
charge from hospital (T0) and five months later (T1, one
month after the last home visit). The patients’ medical
history, medication use and other clinical variables at
discharge are obtained from the hospital discharge letter
at T0. Clinical variables are obtained with a case report
form from the primary care physician at T1.
The primary outcome in this study is diabetes-related
distress, measured with the Problem Areas in Diabetes
(PAID) scale. The PAID is a self-reported questionnaire
measuring common negative emotions related to living
with diabetes and is positively associated with relevant
psychosocial measures of distress, including general
emotional distress, and negatively associated with self-
care behaviour [55]. The questionnaire is well validated
and responsive to change in a heterogeneous group of
diabetes patients [21,56]. Because distress comprises all
important aspects of coping with an ACE for type 2 dia-
betes patients, the PAID is a good comprehensive pri-
mary outcome measure in this study.
Secondary outcomes are well-being, health status, anx-
iety, depression and clinical variables (HbA1c, blood
pressure, cholesterol levels and, body mass index). These
variables are mediated by self-management, which in
turn is influenced by self-efficacy and illness representa-
tions (see Figure 1).
Sample size
The trial is designed to detect a change in diabetes-
related distress as measured by the total score of the
PAID. No consensus exists about minimal important dif-
ferences (MID) of distress measured with this question-
naire. Therefore, we set the MID at half a standard
deviation, corresponding to a medium Cohen’s effect
size [57]. An analysis of covariance (ANCOVA) will be
performed to compare the intervention and controlgroups while controlling for baseline PAID. Assuming a
two-sided significance level of 5%, a power of 80% and a
correlation of ρ = 0.3 (“medium” effect size) between
baseline en follow-up scores on the PAID, this leads to a
sample size of 77 per group [58]. To account for dropout
(i.e., no follow-up assessments obtained), we intend to
include 100 people in both the intervention and control
group.
Statistical analyses
Data will be analysed according to the intention-to-treat
principle, including all patients for whom a follow-up as-
sessment is available. No imputation will be done, as the
proposed analysis is already valid under the missing at
random assumption [59]. The primary analysis will be
an ANCOVA on the change from baseline in total score
on the PAID. The model will at least include treatment
(intervention or control condition) as factor and the
baseline PAID as covariate. ANCOVA has two major ad-
vantages compared to a t-test on post-treatment or
change scores [60]: 1) ANCOVA correct for baseline
score, so possible baseline differences between groups
are accounted for without being influenced by regression
to the mean; and 2) ANCOVA has a greater power to
detect a treatment effect. Secondary outcomes will be
analysed similarly. The Holm-Bonferroni correction will
be used to adjust for multiple testing [61]. Exploratory
sub-group analyses will be performed to assess the im-
pact of age (young vs. old, cut-off: median), gender (man
vs. woman), home situation (living alone vs. not living
alone) and type of ACE (group 1: MI + CABG or only
CABG; group 2: MI + PCI or only PCI; group 3: MI or
instable angina pectoris without invasive intervention)
on outcomes. Furthermore, a comparison will be per-
formed to investigate whether the improvement of self-
efficacy shows the same pattern of improvement as the
PAID, by correlating improvement in self-efficacy with
improvement in PAID at individual level within treat-
ment groups.
Discussion
After an acute coronary event diabetic patients have di-
minished QOL and more diabetes-related distress com-
pared to patients without type 2 diabetes. These patients
seem to be in need of additional support in the period
after discharge, in addition to the usual care. The American
Diabetes Association suggests that specific attention for
diabetes is needed when patients are discharged from
the hospital after an ACE. The Task Force on Diabetes
and Cardiovascular Diseases of the European Society of
Cardiology (ESC) and the European Association for the
Study of Diabetes (EASD) focus specifically on patients
with both diabetes and cardiovascular disease. Since
diabetes is associated with increased risk of mortality and
Table 1 Description of questionnaires
Questionnaire Description Score range
Problem Areas in Diabetes
questionnaire (PAID) [21]
Self-reported questionnaire consisting of twenty
statements identified as common negative emotions
related to living with diabetes.
Each item is rated on a 5-point Likert scale, ranging
from 0 (“not a problem”) to 4 (“a serious problem”).
The total score is transformed to a 0–100 scale, with
higher score representing higher distress.
WHO-Five Well-being Index
(WHO-5) [46]
The five items covering positive mood (good spirits,
relaxation), vitality (being active and waking up fresh
and rested), and general interests (being interested in
things) in the past two weeks.
The degree to which these feelings were present is
rated on a 6-point Likert scale, ranging from 0 (“not
present”) to 5 (“constantly present”)
The scores are transformed to a 0–100 scale, with
higher score representing better well-being.
Euroqol 5 Dimensions (EQ-5D)/
Euroqol Visual Scale (EQ-VAS) [47]
The EQ-5D measures general health status on five
dimensions:
The EQ-5D scores was computed using the MVH-A1
algorithm
1) Mobility Range −0.594 to + 1.00
2) Self-care 0: (equal to) death
3) Usual activities 1: full health
4) Pain/discomfort Negative values: a health score worse
5) Anxiety/depression than death
The EQ-VAS measures the overall health state on a
graded, vertical line.
Range 0 to 100
0: worst imaginable health state
100: best imaginable health state.
Hospital Anxiety and Depression
Scale (HADS) [48]
A questionnaire measuring anxiety (7 items) and
depression (7 items)
Each item is rated on a 4-point Likert scale, ranging
from “Most of the time” to “not at all”.
Sum scores for each subscale 0–21, higher score
indicate more severe anxiety/depression.
International Physical Activity
Questionnaire (IPAQ) [49]
29 Items measure how many days’ physical activities
are performed during the past seven days in four
domains (work, transportation, housework and leisure-
time)
Measuring domain-specific activity scores. A total
physical activity score is calculated as the sum of the
number of minutes of total moderate activity for each
subdomain, plus two times the number of minutes of




Measuring overprotection by the partner. Five items
measure active engagement, eight items measure
protective buffering and six items measure
overprotection.
Each items is scored on a 5-point Likert scale, ranging
from 1 (“never”) to t 5 (“very often”).
Total score: 15-95
Summary of the Diabetes
Self-Care Activities Measure
(SDSCA) [51]
Eleven items assessing several aspects of the diabetes
regimen: general diet, specific diet, exercise, blood
glucose testing, foot care, and smoking. Items
measure how many days a patient has performed
self-care activities in the last seven days.
Ten items are rated on an 8-point Likert scale, measur-
ing how many days an activity is performed in the last
week. One items measures smoking status (yes/no)
and the amount of cigarettes smoked in the last
week. Each of the domains is measured separately.
Diabetes Coping Measure (DCM) [52] Four scales measuring diabetes coping: tackling spirit,
avoidance, passive resignation and diabetes
integration.
The 20 items are measures on a 5-point Likert scale,
ranging from 1 (“disagree”) to 5 (“agree strongly”)
Higher scores on tackling spirit and diabetes
integration indicate more adaptive coping. Higher
scores on passive resignation and avoidance indicate
poor coping.
Confidence in Diabetes Self-care
questionnaire (CIDS) [53]
Questionnaire adapted to type 2 diabetes patients.
Twenty items measure diabetes-specific self-efficacy.
Each item is scored on a 5-point Likert scale ranging
from 1 (“No, I don’t believe I’m able to do this”) to 5
(“Yes, I’m sure I’m able to do this”).
The total score is transformed to a 0–100 scale, with
higher score indicating higher self-efficacy.
Illness Perception Questionnaire (IPQ)
– short version [54]
Questionnaire assessing the cognitive representation
of illness, focuses on seven scales, assessing (1)
Timeline acute/chronic and (2) Timeline cyclical (3)
Consequences (4) Personal control (5) Treatment control
(6) Illness coherence (7) Emotional representation
Eight questions answered on an 11-point Likert scale,
ranging from 0 to 10, with the scale for each question
having a different meaning. For example when meas-
uring concerns about the illness, the scale ranges from
0 (no at all concerned) to 10 (extremely concerned).
The three most important causes of the illness are
measured with an open ended question.
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phasise that secondary prevention is of great importance
in these patients. According to the guidelines of the ESC
and EASD secondary prevention includes altering lifestyle
habits, smoking cessation, blocking the renin-angiotensin
system, blood pressure control, lipid-lowering medication
and blood glucose control [62]. Since secondary preven-
tion comprises altering lifestyle and increased medication
use, this can be very burdensome, especially in patients
who already had to cope with diabetes. Therefore, self-
management support is very important for these patients.
Our intervention can help type 2 diabetes patients who
experienced an ACE to preform preventive actions and
self-management, and reduce distress. Since we use an
attention-control group, we may conclude at the end of
the study that the results of our intervention are the net re-
sult of the content and performance of the planned visits
minus just ‘attention’ for the situation a person got in after
the discharge from hospital.
In this study, all nurses involved are paid for ten hours
per patient, which includes the home visits, training
course and evaluative meetings. They will also receive a
reimbursement for travel costs. If the current interven-
tion proves to be effective and implementation on a
large scale is considered, a large number of nurses could
be employed and trained to deliver the additional care,
making the intervention less expensive than in this study
since they have less travel distances and costs. Whether
health insurance companies would pay for the interven-
tion will of course depend on marketing strategies and
available resources in due time.
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